U.S. sales reports suggest Capcom's action RPG is blowing the competition out of the Brine.

It's natural that everyone's been a little antsy about Final Fantasy 7: Rebirth lately. For weeks, analysts and fans have been discussing the game's potential underperformance compared to its predecessor, Remake, amid worries this might impact the future of the 7 Remake trilogy. Today, we got a …

In today's Daily Fix: Final Fantasy 7 Rebirth was released just two months ago, but there are signs that the game is falling short of sales expectations. The game's sales are slow compared to its predecessor Final Fantasy 7 Remake, and last summer's Final Fantasy 16. It also doesn't help that the game is a PS5 exclusive (there are fewer PS5's currently sold than PS4's), and it costs $10 more than FF7 Remake did back in 2020. In other news, a new patch is coming for Dragon's Dogma 2 that will bring some much-needed fixes, like one pertaining to the dragonsplague illness. And finally, Helldivers are really good at committing genocide, completing an order to kill 2 billion Terminids in less than a week (they did it in under 24 hours).